Ramos-Arroyo syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

(Redirected from Ramos Arroyo Clark syndrome)

Autosomal dominant - en

Ramos-Arroyo syndrome is a rare genetic disorder characterized by a combination of distinctive facial features, developmental delay, and other congenital anomalies. The syndrome was first described by Dr. Carmen Ramos-Arroyo in the early 1980s.

Clinical Features[edit | edit source]

Individuals with Ramos-Arroyo syndrome typically present with a range of clinical features, including:

Facial Features[edit | edit source]

The facial features associated with Ramos-Arroyo syndrome may include:

Genetics[edit | edit source]

Ramos-Arroyo syndrome is believed to follow an autosomal recessive inheritance pattern. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in Ramos-Arroyo syndrome have not yet been identified.

Diagnosis[edit | edit source]

The diagnosis of Ramos-Arroyo syndrome is primarily based on clinical evaluation and the identification of characteristic features. Genetic testing may be used to support the diagnosis, although the specific genetic mutations associated with the syndrome are not well-defined.

Management[edit | edit source]

There is no cure for Ramos-Arroyo syndrome, and treatment is primarily supportive and symptomatic. Management may include:

Prognosis[edit | edit source]

The prognosis for individuals with Ramos-Arroyo syndrome varies depending on the severity of the symptoms and the presence of associated health issues. Early intervention and supportive care can improve the quality of life for affected individuals.

Related Pages[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

-


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD